Obesity and the risk and outcome of infection

International Journal of Obesity

Volumn 37, Issue 3, 2013, Pages 333-340

  Huttunen, R ^a   Syrjanen J ^b  

^a UNIVERSITY OF TAMPERE MEDICAL SCHOOL   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

infection; influenza; nosocomial; outcome; pneumonia; the risk of

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; FIBRINOGEN; LEPTIN;

ADIPOCYTE; BLOODSTREAM INFECTION; CELL DIFFERENTIATION; CELLULITIS; CHRONIC INFLAMMATION; COLON SURGERY; CRITICALLY ILL PATIENT; CYTOKINE RELEASE; DISEASE ASSOCIATION; HEART SURGERY; HOSPITAL INFECTION; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOSURVEILLANCE; INFECTION; INFECTION RISK; INFLUENZA A (H1N1); INTENSIVE CARE; MACROPHAGE; META ANALYSIS (TOPIC); MORTALITY; OBESITY; ORTHOPEDIC SURGERY; PANCREATICODUODENECTOMY; PANCREATITIS; PATHOPHYSIOLOGY; PERIODONTITIS; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; PROGNOSIS; RECTUM SURGERY; REVIEW; SEPSIS; SEPTIC SHOCK; SKIN INFECTION; SPAIN; SURGICAL INFECTION; SYSTEMATIC REVIEW (TOPIC); URINARY TRACT INFECTION; VIRUS HEPATITIS;

ADIPOCYTES; ANTI-INFECTIVE AGENTS; COMMUNITY-ACQUIRED INFECTIONS; COST OF ILLNESS; CROSS INFECTION; FEMALE; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; LEUKOCYTES; MALE; OBESITY; PANCREATITIS; PERIODONTITIS; PNEUMONIA; PROGNOSIS; RECEPTOR CROSS-TALK; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SKIN DISEASES, INFECTIOUS;

EID: 84875228575     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2012.62     Document Type: Review

References (140)

1. Berghofer A, Pischon T, Reinhold T, Apovian CM, Sharma AM, Willich SN. Obesity prevalence from a European perspective: a systematic review. BMC Public Health 2008; 8: 200.
2. WHO. WHO obesity: preventing and managing the global epidemic. Report of the WHO consultation. World Health Organ Tech Rep Ser 2000; 894: 1-253.
3. Abdullah A, Wolfe R, Stoelwinder JU, de Courten M, Stevenson C, Walls HL et al. The number of years lived with obesity and the risk of all-cause and causespecific mortality. Int J Epidemiol 2011; 40: 985-996.
4. Huttunen R, Syrjanen J. Obesity and the outcome of infection. Lancet Infect Dis 2010; 10: 442-443.
5. Falagas ME, Kompoti M. Obesity and infection. Lancet Infect Dis 2006; 6: 438-446.
6. Falagas ME, Athanasoulia AP, Peppas G, Karageorgopoulos DE. Effect of body mass index on the outcome of infections: a systematic review. Obes Rev 2009; 10: 280-289.
7. Falagas ME, Karageorgopoulos DE. Adjustment of dosing of antimicrobial agents for bodyweight in adults. Lancet 2010; 375: 248-251.
8. Kornum JB, Norgaard M, Dethlefsen C, Due KM, Thomsen RW, Tjonneland A et al. Obesity and risk of subsequent hospitalisation with pneumonia. Eur Respir J 2010; 36: 1330-1336
9. Almirall J, Bolibar I, Serra-Prat M, Roig J, Hospital I, Carandell E et al. New evidence of risk factors for community-acquired pneumonia: a population-based study. Eur Respir J 2008; 31: 1274-1284
10. Baik I, Curhan GC, Rimm EB, Bendich A, Willett WC, Fawzi WW. A prospective study of age and lifestyle factors in relation to community-acquired pneumonia in US men and women. Arch Intern Med 2000; 160: 3082-3088
11. Schnoor M, Klante T, Beckmann M, Robra BP, Welte T, Raspe H et al. Risk factors for community-acquired pneumonia in German adults: the impact of children in the household. Epidemiol Infect 2007; 135: 1389-1397
12. Choban PS, Heckler R, Burge JC. Flancbaum L Increased incidence of nosocomial infections in obese surgical patients. Am Surg 1995; 61: 1001-1005
13. Vessey MP, Metcalfe MA, McPherson K, Yeates D. Urinary tract infection in relation to diaphragm use and obesity. Int J Epidemiol 1987; 16: 441-444
14. Marti A, Marcos A, Martinez JA. Obesity and immune function relationships. Obes Rev 2001; 2: 131-140
15. Nave H, Beutel G, Kielstein JT. Obesity-related immunodeficiency in patients with pandemic influenza H1N1. Lancet Infect Dis 2011; 11: 14-15
16. Havel PJ, Kasim-Karakas S, Mueller W, Johnson PR, Gingerich RL, Stern JS. Relationship of plasma leptin to plasma insulin and adiposity in normal weight and overweight women: effects of dietary fat content and sustained weight loss. J Clin Endocrinol Metab 1996; 81: 4406-4413
17. Koch A, Sanson E, Voigt S, Helm A, Trautwein C, Tacke F. Serum adiponectin upon admission to the intensive care unit may predict mortality in critically ill patients. J Crit Care 2011; 26: 166-174
18. Festa A, D0Agostino Jr R, Williams K, Karter AJ, Mayer-Davis EJ, Tracy RP et al. The relation of body fat mass and distribution to markers of chronic inflammation. Int J Obes Relat Metab Disord 2001; 25: 1407-1415
19. Brown CV, Neville AL, Rhee P, Salim A, Velmahos GC, Demetriades D. The impact of obesity on the outcomes of 1,153 critically injured blunt trauma patients. J Trauma 2005; 59: 1048-1051discussion 1051
20. Anzueto A, Frutos-Vivar F, Esteban A, Bensalami N, Marks D, Raymondos K et al. Influence of body mass index on outcome of the mechanically ventilated patients. Thorax 2011; 66: 66-73
21. Hogue Jr. CW, Stearns JD, Colantuoni E, Robinson KA, Stierer T, Mitter N et al. The impact of obesity on outcomes after critical illness: a meta-analysis. Intensive Care Med 2009; 35: 1152-1170
22. Ashburn DD, DeAntonio A, Reed MJ. Pulmonary system and obesity. Crit Care Clin 2010; 26: 597-602
23. Yosipovitch G, DeVore A, Dawn A. Obesity and the skin: skin physiology and skin manifestations of obesity. J Am Acad Dermatol 2007; 56: 901-916quiz 917-20
24. Louie JK, Acosta M, Samuel MC, Schechter R, Vugia DJ, Harriman K et al. A novel risk factor for a novel virus: obesity and 2009 pandemic influenza A (H1N1). Clin Infect Dis 2011; 52: 301-312
25. Yu H, Feng Z, Uyeki TM, Liao Q, Zhou L, Feng L et al. Risk factors for severe illness with 2009 pandemic influenza A (H1N1) virus infection in China. Clin Infect Dis 2011; 52: 457-465
26. Lucas S. Predictive clinicopathological features derived from systematic autopsy examination of patients who died with A/H1N1 influenza infection in the UK 2009-10 pandemic. Health Technol Assess 2010; 14: 83-114
27. Fuhrman C, Bonmarin I, Bitar D, Cardoso T, Duport N, Herida M et al. Adult intensive-care patients with 2009 pandemic influenza A(H1N1) infection. Epidemiol Infect 2011; 139: 1202-1209
28. Santa-Olalla Peralta P, Cortes-Garcia M, Vicente-Herrero M, Castrillo-Villamandos C, Arias-Bohigas P, Pachon-del Amo I et al. Risk factors for disease severity among hospitalised patients with 2009 pandemic influenza A (H1N1) in Spain, April-December 2009. Euro Surveill 2010; 15: pii: 19667
29. Falagas ME, Koletsi PK, Baskouta E, Rafailidis PI, Dimopoulos G, Karageorgopoulos DE. Pandemic A(H1N1) 2009 influenza: review of the Southern Hemisphere experience. Epidemiol Infect 2011; 139: 27-40
30. Viasus D, Pano-Pardo JR, Pachon J, Campins A, Lopez-Medrano F, Villoslada A et al. Factors associated with severe disease in hospitalized adults with pandemic (H1N1) 2009 in Spain. Clin Microbiol Infect 2011; 17: 738-746
31. Nguyen-Van-Tam JS, Openshaw PJ, Hashim A, Gadd EM, Lim WS, Semple MG et al. Risk factors for hospitalisation and poor outcome with pandemic A/H1N1 influenza: United Kingdom first wave (May-September 2009). Thorax 2010; 65: 645-651
32. Satterwhite L, Mehta A, Martin GS. Novel findings from the second wave of adult pH1N1 in the United States. Crit Care Med 2010; 38: 2059-2061
33. Diaz E, Rodriguez A, Martin-Loeches I, Lorente L, del Mar Martin M, Pozo JC et al. Impact of obesity in patients infected with 2009 influenza A(H1N1). Chest 2010; 139: 382-386
34. Riquelme R, Jimenez P, Videla AJ, Lopez H, Chalmers J, Singanayagam A et al. Predicting mortality in hospitalized patients with 2009 H1N1 influenza pneumonia. Int J Tuberc Lung Dis 2011; 15: 542-566
35. Fezeu L, Julia C, Henegar A, Bitu J, Hu FB, Grobbee DE et al. Obesity is associated with higher risk of intensive care unit admission and death in influenza A (H1N1) patients: a systematic review and meta-analysis. Obes Rev 2011; 12: 653-659
36. Van Kerkhove MD, Vandemaele KA, Shinde V, Jaramillo-Gutierrez G, Koukounari A, Donnelly CA et al. Risk factors for severe outcomes following 2009 influenza A (H1N1) infection: a global pooled analysis. PLoS Med 2011; 8: e1001053
37. Kwong JC, Campitelli MA. Rosella LC Obesity and respiratory hospitalizations during influenza seasons in Ontario, Canada: a cohort study. Clin Infect Dis 2011; 53: 413-421
38. Hagau N, Slavcovici A, Gonganau DN, Oltean S, Dirzu DS, Brezoszki ES et al. Clinical aspects and cytokine response in severe H1N1 influenza A virus infection. Crit Care 2010; 14: R203
39. Sheridan PA, Paich HA, Handy J, Karlsson EA, Hudgens MG, Sammon AB et al. Obesity is associated with impaired immune response to influenza vaccination in humans. Int J Obes (Lond) 2011; e-pub ahead of print 25 October 2011; doi:10.1038/ijo.2011.208
40. Smith AG, Sheridan PA, Tseng RJ, Sheridan JF, Beck MA. Selective impairment in dendritic cell function and altered antigen-specific CD8 T-cell responses in diet-induced obese mice infected with influenza virus. Immunology 2009; 126: 268-279
41. Semins MJ, Shore AD, Makary MA, Weiner J, Matlaga BR. The impact of obesity on urinary tract infection risk. Urology 2012; 79: 266-269
42. Ribera MC, Pascual R, Orozco D, Perez Barba C, Pedrera V, Gil V. Incidence and risk factors associated with urinary tract infection in diabetic patients with and without asymptomatic bacteriuria. Eur J Clin Microbiol Infect Dis 2006; 25: 389-393
43. Bochicchio GV, Joshi M, Bochicchio K, Nehman S, Tracy JK, Scalea TM. Impact of obesity in the critically ill trauma patient: a prospective study. J Am Coll Surg 2006; 203: 533-538
44. Wurzinger B, Dunser MW, Wohlmuth C, Deutinger MC, Ulmer H, Torgersen C et al. The association between body-mass index and patient outcome in septic shock: a retrospective cohort study. Wien Klin Wochenschr 2010; 122: 31-36
45. Basu JK, Jeketera CM, Basu D. Obesity and its outcomes among pregnant South African women. Int J Gynaecol Obstet 2010; 110: 101-104
46. Usha Kiran TS, Hemmadi S, Bethel J, Evans J. Outcome of pregnancy in a woman with an increased body mass index. Bjog 2005; 112: 768-772
47. Bamgbade OA, Rutter TW, Nafiu OO, Dorje P. Postoperative complications in obese and nonobese patients. World J Surg 2007; 31: 556-560; discussion 561
48. Saito T, Shimazaki Y, Sakamoto M. Obesity and periodontitis. N Engl J Med 1998; 339: 482-483
49. Suvan J, D0Aiuto F, Moles DR, Petrie A, Donos N. Association between overweight/obesity and periodontitis in adults. A systematic review. Obes Rev 2011; 12: e381-e404
50. Chaffee BW, Weston SJ. Association between chronic periodontal disease and obesity: a systematic review and meta-analysis. J Periodontol 2010; 81: 1708-1724
51. Tomofuji T, Ekuni D, Yamanaka R, Kusano H, Azuma T, Sanbe T et al. Chronic administration of lipopolysaccharide and proteases induces periodontal inflammation and hepatic steatosis in rats. J Periodontol 2007; 78: 1999-2006
52. Saito T, Shimazaki Y, Kiyohara Y, Kato I, Kubo M, Iida M et al. The severity of periodontal disease is associated with the development of glucose intolerance in non-diabetics: the Hisayama study. J Dent Res 2004; 83: 485-490
53. Eber MR, Laxminarayan R, Perencevich EN, Malani A. Clinical and economic outcomes attributable to health care-associated sepsis and pneumonia. Arch Intern Med 2010; 170: 347-353
54. Kaye KS, Marchaim D, Chen TY, Chopra T, Anderson DJ, Choi Y et al. Predictors of nosocomial bloodstream infections in older adults. J Am Geriatr Soc 2011; 59: 622-627
55. Edmonds RD, Cuschieri J, Minei JP, Rosengart MR, Maier RV, Harbrecht BG et al. Body adipose content is independently associated with a higher risk of organ failure and nosocomial infection in the nonobese patient postinjury. J Trauma 2011; 70: 292-298
56. Serrano PE, Khuder SA, Fath JJ. Obesity as a risk factor for nosocomial infections in trauma patients. J Am Coll Surg 2010; 211: 61-67
57. Dossett LA, Dageforde LA, Swenson BR, Metzger R, Bonatti H, Sawyer RG et al. Obesity and site-specific nosocomial infection risk in the intensive care unit. Surg Infect (Larchmt) 2009; 10: 137-142
58. Sakr Y, Madl C, Filipescu D, Moreno R, Groeneveld J, Artigas A et al. Obesity is associated with increased morbidity but not mortality in critically ill patients. Intensive Care Med 2008; 34: 1999-2009
59. Bercault N, Boulain T, Kuteifan K, Wolf M, Runge I, Fleury JC. Obesity-related excess mortality rate in an adult intensive care unit: a risk-adjusted matched cohort study. Crit Care Med 2004; 32: 998-1003
60. Frat JP, Gissot V, Ragot S, Desachy A, Runge I, Lebert C et al. Impact of obesity in mechanically ventilated patients: a prospective study. Intensive Care Med 2008; 34: 1991-1998
61. Olsen MA, Higham-Kessler J, Yokoe DS, Butler AM, J Vostok, KB Stevenson et al. Developing a risk stratification model for surgical site infection after abdominal hysterectomy. Infect Control Hosp Epidemiol 2009; 30: 1077-1083
62. Waisbren E, Rosen H, Bader AM, Lipsitz SR, Rogers Jr. SO, Eriksson E. Percent body fat and prediction of surgical site infection. J Am Coll Surg 2010; 210: 381-389
63. Di Leo A, Piffer S, Ricci F, Manzi A, Poggi E, Porretto V et al. Surgical site infections in an Italian surgical ward: a prospective study. Surg Infect (Larchmt) 2009; 10: 533-538
64. Beldi G, Bisch-Knaden S, Banz V, Muhlemann K, Candinas D. Impact of intraoperative behavior on surgical site infections. Am J Surg 2009; 198: 157-162
65. Su Z, Koga R, Saiura A, Natori T, Yamaguchi T, Yamamoto J. Factors influencing infectious complications after pancreatoduodenectomy. J Hepatobiliary Pancreat Sci 2010; 17: 174-179
66. Greenblatt DY, Kelly KJ, Rajamanickam V, Wan Y, Hanson T, Rettammel R et al. Preoperative factors predict perioperative morbidity and mortality after pancreaticoduodenectomy. Ann Surg Oncol 2011; 18: 2126-2135
67. Healy LA, Ryan AM, Sutton E, Younger K, Mehigan B, Stephens R et al. Impact of obesity on surgical and oncological outcomes in the management of colorectal cancer. Int J Colorectal Dis 2010; 25: 1293-1299
68. Okabayashi T, Nishimori I, Yamashita K, Sugimoto T, Yatabe T, Maeda H et al. Risk factors and predictors for surgical site infection after hepatic resection. J Hosp Infect 2009; 73: 47-53
69. Kakarla VR, Nandipati K, Lalla M, Castro A, Merola S. Are laparoscopic bariatric procedures safe in superobese (BMI 4/50 kg/m(2)) patients? An NSQIP data analysis. Surg Obes Relat Dis 2011; 7: 452-458
70. Merkow RP, Bilimoria KY, McCarter MD, Bentrem DJ. Effect of body mass index on short-term outcomes after colectomy for cancer. J Am Coll Surg 2009; 208: 53-61
71. Gervaz P, Bandiera-Clerc C, Buchs NC, Eisenring MC, Troillet N, Perneger T et al. Scoring system to predict the risk of surgical-site infection after colorectal resection. Br J Surg 2012; 99: 589-595
72. Giles KA, Hamdan AD, Pomposelli FB, Wyers MC, Siracuse JJ, Schermerhorn ML. Body mass index: surgical site infections and mortality after lower extremity bypass from the National Surgical Quality Improvement Program 2005-2007. Ann Vasc Surg 2010; 24: 48-56
73. Dodds Ashley ES, Carroll DN, Engemann JJ, Harris AD, Fowler Jr. VG, Sexton DJ et al. Risk factors for postoperative mediastinitis due to methicillin-resistant Staphylococcus aureus. Clin Infect Dis 2004; 38: 1555-1560
74. Spelman DW, Russo P, Harrington G, Davis BB, Rabinov M, Smith JA et al. Risk factors for surgical wound infection and bacteraemia following coronary artery bypass surgery. Aust N Z J Surg 2000; 70: 47-51
75. Go l MK, Karahan M, Ulus AT, Erdil N, Iscan Z, Karabiber N et al. Bloodstream, respiratory, and deep surgical wound infections after open heart surgery. J Card Surg 1998; 13: 252-259
76. Ahmed D, Cheema FH, Ahmed YI, Schaefle KJ, Azam SI, Sami SA et al. Incidence and predictors of infection in patients undergoing primary isolated coronary artery bypass grafting: a report from a tertiary care hospital in a developing country. J Cardiovasc Surg (Torino) 2011; 52: 99-104
77. Al-Zaru IM, Ammouri AA, Al-Hassan MA, Amr AA. Risk factors for deep sternal wound infections after cardiac surgery in Jordan. J Clin Nurs 2010; 19: 1873-1881
78. Olsen MA, Lock-Buckley P, Hopkins D, Polish LB, Sundt TM, Fraser VJ. The risk factors for deep and superficial chest surgical-site infections after coronary artery bypass graft surgery are different. J Thorac Cardiovasc Surg 2002; 124: 136-145
79. Le Guillou V, Tavolacci MP, Baste JM, Hubscher C, Bedoit E, Bessou JP et al. Surgical site infection after central venous catheter-related infection in cardiac surgery. Analysis of a cohort of 7557 patients. J Hosp Infect 2011; 79: 236-241
80. Sharma M, Fakih MG, Berriel-Cass D, Meisner S, Saravolatz L, Khatib R. Harvest surgical site infection following coronary artery bypass grafting: risk factors, microbiology, and outcomes. Am J Infect Control 2009; 37: 653-657
81. Olsen MA, Sundt TM, Lawton JS, Damiano Jr. RJ, Hopkins-Broyles D, Lock-Buckley P et al. Risk factors for leg harvest surgical site infections after coronary artery bypass graft surgery. J Thorac Cardiovasc Surg 2003; 126: 992-999
82. Dowsey MM, Choong PF. Obese diabetic patients are at substantial risk for deep infection after primary TKA. Clin Orthop Relat Res 2009; 467: 1577-1581
83. Peel TN, Dowsey MM, Daffy JR, Stanley PA, Choong PF, Buising KL. Risk factors for prosthetic hip and knee infections according to arthroplasty site. J Hosp Infect 2011; 79: 129-133
84. McCalden RW, Charron KD, Macdonald SJ, Bourne RB, Naudie DD. Does morbid obesity affect the outcome of total hip replacement?: an analysis of 3290 THRs. J Bone Joint Surg Br 2011; 93: 321-325
85. Linam WM, Margolis PA, Staat MA, Britto MT, Hornung R, Cassedy A et al. Risk factors associated with surgical site infection after pediatric posterior spinal fusion procedure. Infect Control Hosp Epidemiol 2009; 30: 109-116
86. Towfigh S, Chen F, Katkhouda N, Kelso R, Sohn H, Berne TV et al. Obesity should not influence the management of appendicitis. Surg Endosc 2008; 22: 2601-2605
87. Zahr F, Genovese E, Mathier M, Shullo M, Lockard K, Zomak R et al. Obese patients and mechanical circulatory support: weight loss, adverse events, and outcomes. Ann Thorac Surg 2011; 92: 1420-1426
88. Torgerson JS, Lindroos AK, Naslund I, Peltonen M. Gallstones, gallbladder disease, and pancreatitis: cross-sectional and 2-year data from the swedish obese subjects (SOS) and SOS reference studies. Am J Gastroenterol 2003; 98: 1032-1041
89. Martinez J, Sanchez-Paya J, Palazon JM, Suazo-Barahona J, Robles-Diaz G, Perez-Mateo M. Is obesity a risk factor in acute pancreatitis? A meta-analysis. Pancreatology 2004; 4: 42-48
90. Martinez J, Johnson CD, Sanchez-Paya J, de Madaria E, Robles-Diaz G, Perez-Mateo M. Obesity is a definitive risk factor of severity and mortality in acute pancreatitis: an updated meta-analysis. Pancreatology 2006; 6: 206-209
91. Sempere L, Martinez J, de Madaria E, Lozano B, Sanchez-Paya J, Jover R et al. Obesity and fat distribution imply a greater systemic inflammatory response and a worse prognosis in acute pancreatitis. Pancreatology 2008; 8: 257-264
92. Evans AC, Papachristou GI, Whitcomb DC. Obesity and the risk of severe acute pancreatitis. Minerva Gastroenterol Dietol 2010; 56: 169-179
93. Dupuy A, Benchikhi H, Roujeau JC, Bernard P, Vaillant L, Chosidow O et al. Risk factors for erysipelas of the leg (cellulitis): case-control study. Bmj 1999; 318: 1591-1594
94. Karppelin M, Siljander T, Vuopio-Varkila J, Kere J, Huhtala H, Vuento R et al. Factors predisposing to acute and recurrent bacterial non-necrotizing cellulitis in hospitalized patients: a prospective case-control study. Clin Microbiol Infect 2010; 16: 729-734
95. Bartholomeeusen S, Vandenbroucke J, Truyers C, Buntinx F. Epidemiology and comorbidity of erysipelas in primary care. Dermatology 2007; 215: 118-122
96. Bjornsdottir S, Gottfredsson M, Thorisdottir AS, Gunnarsson GB, Rikardsdottir H, Kristjansson M et al. Risk factors for acute cellulitis of the lower limb: a prospective case-control study. Clin Infect Dis 2005; 41: 1416-1422
97. Pereira de Godoy JM, Galacini Massari P, Yoshino Rosinha M, Marinelli Brandao R, Foroni Casas AL. Epidemiological data and comorbidities of 428 patients hospitalized with erysipelas. Angiology 2010; 61: 492-494
98. Sreeramoju P, Porbandarwalla NS, Arango J, Latham K, Dent DL, Stewart RM et al. Recurrent skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus requiring operative debridement. Am J Surg 2011; 201: 216-220
99. Carratala J, Roson B, Fernandez-Sabe N, Shaw E, del Rio O, Rivera A et al. Factors associated with complications and mortality in adult patients hospitalized for infectious cellulitis. Eur J Clin Microbiol Infect Dis 2003; 22: 151-157.
100. Lo Iacono O, Venezia G, Petta S, Mineo C, De Lisi S, Di Marco V et al. The impact of insulin resistance, serum adipocytokines and visceral obesity on steatosis and fibrosis in patients with chronic hepatitis C. Aliment Pharmacol Ther 2007; 25: 1181-1191.
101. Delgado-Borrego A, Healey D, Negre B, Christofi M, Sabharwal S, Ludwig DA et al. Influence of body mass index on outcome of pediatric chronic hepatitis C virus infection. J Pediatr Gastroenterol Nutr 2010; 51: 191-197.
102. Tolman KG, Fonseca V, Tan MH, Dalpiaz A. Narrative review: hepatobiliary disease in type 2 diabetes mellitus. Ann Intern Med 2004; 141: 946-956.
103. Shintani Y, Fujie H, Miyoshi H, Tsutsumi T, Tsukamoto K, Kimura S et al. Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance. Gastroenterology 2004; 126: 840-848.
104. Yen SL, Chiu TY, Lin YC, Lee YC, Lee LT, Huang KC. Obesity and hepatitis B infection are associated with increased risk of metabolic syndrome in university freshmen. Int J Obes (Lond) 2008; 32: 474-480.
105. Jain R, Chung SM, Jain L, Khurana M, Lau SW, Lee JE et al. Implications of obesity for drug therapy: limitations and challenges. Clin Pharmacol Ther 2011; 90: 77-89.
106. Roe JL, Fuentes JM, Mullins ME. Underdosing of common antibiotics for obese patients in the ED. Am J Emerg Med 2011; e-pub ahead of print 12 December 2011.
107. Hall 2nd RG, Payne KD, Bain AM, Rahman AP, Nguyen ST, Eaton SA et al. Multicenter evaluation of vancomycin dosing: emphasis on obesity. Am J Med 2008; 121: 515-518.
108. Pea F, Cojutti P, Sbrojavacca R, Cadeo B, Cristini F, Bulfoni A et al. TDM-guided therapy with daptomycin and meropenem in a morbidly obese, critically ill patient. Ann Pharmacother 2011; 45: e37.
109. Hollenstein UM, Brunner M, Schmid R, Muller M. Soft tissue concentrations of ciprofloxacin in obese and lean subjects following weight-adjusted dosing. Int J Obes Relat Metab Disord 2001; 25: 354-358.
110. Forse RA, Karam B, MacLean LD, Christou NV. Antibiotic prophylaxis for surgery in morbidly obese patients.. Surgery 1989; 106: 750-756; discussion 756-757.
111. Thorne-Humphrey LM, Goralski KB, Slayter KL, Hatchette TF, Johnston BL, McNeil SA. Oseltamivir pharmacokinetics in morbid obesity (OPTIMO trial). J Antimicrob Chemother 2011; 66: 2083-2091.
112. Cook AM, Martin C, Adams VR, Morehead RS. Pharmacokinetics of intravenous levofloxacin administered at 750 milligrams in obese adults. Antimicrob Agents Chemother 2011; 55: 3240-3243.
113. Utrup TR, Mueller EW, Healy DP, Callcut RA, Peterson JD, Hurford WE. High-dose ciprofloxacin for serious gram-negative infection in an obese, critically ill patient receiving continuous venovenous hemodiafiltration. Ann Pharmacother 2010; 44: 1660-1664.
114. Newman D, Scheetz MH, Adeyemi OA, Montevecchi M, Nicolau DP, Noskin GA et al. Serum piperacillin/tazobactam pharmacokinetics in a morbidly obese individual. Ann Pharmacother 2007; 41: 1734-1739.
115. Tejera A, Santolaria F, Diez ML, Aleman-Valls MR, Gonzalez-Reimers E, Martinez-Riera A et al. Prognosis of community acquired pneumonia (CAP): value of triggering receptor expressed on myeloid cells-1 (TREM-1) and other mediators of the inflammatory response. Cytokine 2007; 38: 117-123.
116. Inoue Y, Koizumi A, Wada Y, Iso H, Watanabe Y, Date C et al. Risk and protective factors related to mortality from pneumonia among middle aged and elderly community residents: the JACC Study. J Epidemiol 2007; 17: 194-202.
117. Corrales-Medina VF, Valayam J, Serpa JA, Rueda AM, Musher DM. The obesity paradox in community-acquired bacterial pneumonia. Int J Infect Dis 2011; 15: e54-e57.
118. LaCroix AZ LS, Milles TP, White L. Prospective study of pneumonia hospitalizations and mortality of U.S. older people: the role of chronic conditions, health behaviors, and nutritional status. Public Health Rep 1989; 104: 350-360.
119. Bochicchio GV, Joshi M, Bochicchio K, Tracy K, Scalea TM. A time-dependent analysis of intensive care unit pneumonia in trauma patients. J Trauma 2004; 56: 296-301discussion 301-3.
120. Smith RL, Chong TW, Hedrick TL, Hughes MG, Evans HL, McElearney ST et al. Does body mass index affect infection-related outcomes in the intensive care unit? Surg Infect (Larchmt) 2007; 8: 581-588.
121. El-Solh A, Sikka P, Bozkanat E, Jaafar W, Davies J. Morbid obesity in the medical ICU. Chest 2001; 120: 1989-1997.
122. Arslan E, Atilgan H, Yavasoglu I. The prevalence of Helicobacter pylori in obese subjects. Eur J Intern Med 2009; 20: 695-697.
123. Perdichizzi G, Bottari M, Pallio S, Fera MT, Carbone M, Barresi G. Gastric infection by Helicobacter pylori and antral gastritis in hyperglycemic obese and in diabetic subjects. New Microbiol 1996; 19: 149-154.
124. Renshaw AA, Rabaza JR, Gonzalez AM, Verdeja JC. Helicobacter pylori infection in patients undergoing gastric bypass surgery for morbid obesity. Obes Surg 2001; 11: 281-283.
125. Wu MS, Lee WJ, Wang HH, Huang SP, Lin JT. A case-control study of association of Helicobacter pylori infection with morbid obesity in Taiwan. Arch Intern Med 2005; 165: 1552-1555.
126. Osawa H. Ghrelin and Helicobacter pylori infection. World J Gastroenterol 2008; 14: 6327-6333.
127. Tatsuguchi A, Miyake K, Gudis K, Futagami S, Tsukui T, Wada K et al. Effect of Helicobacter pylori infection on ghrelin expression in human gastric mucosa. Am J Gastroenterol 2004; 99: 2121-2127.
128. Leung CC, Lam TH, Chan WM, Yew WW, Ho KS, Leung G et al. Lower risk of tuberculosis in obesity. Arch Intern Med 2007; 167: 1297-1304.
129. Palmer CE, Jablon S, Edwards PQ. Tuberculosis morbidity of young men in relation to tuberculin sensitivity and body build. Am Rev Tuberc 1957; 76: 517-539.
130. Dooley KE, Chaisson RE. Tuberculosis and diabetes mellitus: convergence of two epidemics. Lancet Infect Dis 2009; 9: 737-746.
131. Kraft R, Herndon DN, Williams FN, Al-Mousawi AM, Finnerty CC, Jeschke MG. The effect of obesity on adverse outcomes and metabolism in pediatric burn patients. Int J Obes (Lond) 2012; 36: 485-490.
132. Huttunen R, Laine J, Lumio J, Vuento R, Syrjanen J. Obesity and smoking are factors associated with poor prognosis in patients with bacteraemia. BMC Infect Dis 2007; 7: 13.
133. Shor-Posner G, Campa A, Zhang G, Persaud N, Miguez-Burbano MJ, Quesada J et al. When obesity is desirable: a longitudinal study of the Miami HIV-1-infected drug abusers (MIDAS) cohort. J Acquir Immune Defic Syndr 2000; 23: 81-88.
134. Jones CY, Hogan JW, Snyder B, Klein RS, Rompalo A, Schuman P et al. Overweight and human immunodeficiency virus (HIV) progression in women: associations HIV disease progression and changes in body mass index in women in the HIV epidemiology research study cohort. Clin Infect Dis 2003; 37(Suppl 2): S69-S80.
135. French AL, Gawel SH, Hershow R, Benning L, Hessol NA, Levine AM et al. Trends in mortality and causes of death among women with HIV in the United States: a 10-year study. J Acquir Immune Defic Syndr 2009; 51: 399-406.
136. Crum-Cianflone NF, Roediger M, Eberly LE, Ganesan A, Weintrob A, Johnson E et al. Impact of weight on immune cell counts among HIV-infected persons. Clin Vaccine Immunol 2011; 18: 940-946.
137. Tedaldi EM, Brooks JT, Weidle PJ, Richardson JT, Baker RK, Buchacz K et al. Increased body mass index does not alter response to initial highly active antiretroviral therapy in HIV-1-infected patients. J Acquir Immune Defic Syndr 2006; 43: 35-41.
138. Hanrahan CF, Golub JE, Mohapi L, Tshabangu N, Modisenyane T, Chaisson RE et al. Body mass index and risk of tuberculosis and death. Aids 2010; 24: 1501-1508.
139. Wanke CA, Silva M, Knox TA, Forrester J, Speigelman D, Gorbach SL. Weight loss and wasting remain common complications in individuals infected with human immunodeficiency virus in the era of highly active antiretroviral therapy. Clin Infect Dis 2000; 31: 803-805.
140. Hodgson LM, Ghattas H, Pritchitt H, Schwenk A, Payne L, Macallan DC. Wasting and obesity in HIV outpatients. Aids 2001; 15: 2341-2342.